Bird Rock Bio

PharmaceuticalsSeries BUS

Latest round

Series B

Last raised

Mar 2014

Total raised

$68M

Investors

6

About Bird Rock Bio

Establised in 2006 and based in California, US, Bird Rock Bio is a clinical-stage biopharmaceutical company that offers antibody therapeutics for immuno-inflammatory diseases. In August 2023, Skye Bioscience, Inc. portfolio company of 5AM Ventures and Versant Ventures acquired Bird Rock Bio for USD 20 million. Bird Rock Bio’s pipeline centered around Nimacimab, a therapeutic antibody designed to modulate immune and metabolic pathways. The company also developed a broader portfolio of monoclonal antibodies targeting G-protein coupled receptors (GPCRs), leveraging its proprietary discovery platform. These biologics were designed to offer improved specificity and efficacy over traditional small molecule drugs.

Who invested in Bird Rock Bio

6 investors across 4 rounds

See all investors in Bird Rock Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 27, 2014

    Amount

    $15M

    Investors

    Locked

  2. Series A

    Mar 23, 2012

    Amount

    $15M

    Investors

    Locked

  3. Series A

    May 14, 2009

    Amount

    $13M

    Investors

    Locked

  4. Series A

    Jan 7, 2009

    Amount

    $25M

    Investors

    Locked

Questions about Bird Rock Bio

Who invested in Bird Rock Bio?

Bird Rock Bio has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Bird Rock Bio raised?

Bird Rock Bio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Bird Rock Bio last raise money?

Bird Rock Bio's most recent round on record is a Series B, in Mar 2014.

What does Bird Rock Bio do?

Establised in 2006 and based in California, US, Bird Rock Bio is a clinical-stage biopharmaceutical company that offers antibody therapeutics for immuno-inflammatory diseases.

Where is Bird Rock Bio headquartered?

Bird Rock Bio is headquartered in US.

Which VCs invest in companies like Bird Rock Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Bird Rock Bio's stage. Their profiles are linked below.

Raising like Bird Rock Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.